Radiopharm Theranostics Limited Net Fee Amt
Radiopharm Theranostics Limited (RADX) had Net Fee Amt of $384.7 as of 2026-09-09, per its F-3 filed 2026-09-14.
Financial Statements › Notes
ffd:NetFeeAmt · last filed 2026-09-14
- 2026-09-09: Net Fee Amt $384.70.
| Period end | Net Fee Amt |
|---|---|
| 2026-09-09 | $384.70 F-3 · filed 2026-09-14 |